Tenderwize
Back to tender search

Safinamid_TK, HEK, hkk

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2027 · 254 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-06 - Safinamid

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

30 / 100

Risk factors

No guaranteed volume or minimum purchase; the actual revenue depends on the number of prescriptions and competition.

Submission deadlines for timely pharmacy software inclusion are strict (3rd of previous month). Late submissions may de...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount agreements for Safinamid pharmaceutical products under §130a Abs. 8 SGB V.
  • Contract covers all exchangeable finished medicinal products of the contractor.
Show full summary

Open-house discount agreement procedure for pharmaceutical product Safinamid, conducted by Techniker Krankenkasse (TK) on behalf of HEK and hkk. The goal is to conclude non-exclusive rebate contracts with all eligible pharmaceutical entrepreneurs. Contract duration max 12 months from 01.05.2026 to 30.04.2027. Participation possible at any time during the contract period. No individual negotiations; uniform conditions.

Risks

No guaranteed volume or minimum purchase; the actual revenue depends on the number of prescriptions and competition.

Submission deadlines for timely pharmacy software inclusion are strict (3rd of previous month). Late submissions may de...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur within the meaning of §4 Abs. 18 AMG for the offered medicinal products.
  • Company seat must be in Germany, another EU member state, or EEA state (§9 Abs.2 AMG).
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs for the offered products.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Safinamid_TK, HEK, hkk

Discount agreement for Safinamid active ingredient. Scope covers all exchangeable finished medicinal products of the contractor as per framework agreement. Participation of HEK and/or hkk depends on lot designation.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2026 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Apr 29, 2027

Procurement Details

Publication date
26 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
214489-2026

Documents (1)

Similar tenders